Sorafenib is an oral multikinase inhibitor that inhibits tumor growth and proliferation by interfering with several receptor tyrosine kinases involved in the pathogenesis and perpetuation of ...
Sorafenib is used for liver cell carcinoma (HCC) and renal cell carcinoma (RCC), among others. The chemotherapeutic agent belongs to the so-called tyrosine kinase inhibitors, which attack chemical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback